share_log

Piper Sandler Initiates Coverage On Viking Therapeutics With Overweight Rating, Announces Price Target of $74

Piper Sandler Initiates Coverage On Viking Therapeutics With Overweight Rating, Announces Price Target of $74

派杰投资对viking therapeutics启动覆盖,给予增持评级,并宣布目标价为74美元
Benzinga ·  18:48  · 评级/大行评级

Piper Sandler analyst Biren Amin initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Overweight rating and announces Price Target of $74.

派珀·桑德勒分析师比伦·阿明以增持评级启动了对Viking Therapeutics(纳斯达克股票代码:VKTX)的报道,并宣布目标股价为74美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发